13F Data
13F filer · CIK 200406

JOHNSON & JOHNSON

NEW BRUNSWICK, NJ · filing since Q3 2021 · last filing Oct 26, 2026
Reported value
$761.7M
$-37.0M vs prior
Positions
15
New / sold out
0 / 0
Added / reduced
1 / 0
Turnover
0.0%
buys $13.3M · sells $0
Top-10 weight
98.8%

Biggest buys vs Q2 2026

ChangeSecurityShares changeChange %Est. trade value
AddedCEREBRAS SYSTEMS INC+75,063+140.1%+$13.3M

Biggest sells vs Q2 2026

No reduced or sold positions this quarter.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q3 2021: $1.1BQ4 2021: $878.4MQ1 2022: $529.0MQ2 2022: $391.5MQ3 2022: $339.8MQ4 2022: $343.7MQ1 2023: $307.4MQ2 2023: $322.1MQ3 2023: $271.5MQ4 2023: $4.4BQ1 2024: $4.4BQ2 2024: $400.7MQ3 2024: $427.3MQ4 2024: $386.1MQ1 2025: $341.9MQ2 2025: $334.1MQ3 2025: $503.9MQ4 2025: $555.0MQ1 2026: $652.4MQ2 2026: $798.7MQ3 2026: $761.7M
Q3 2021Q3 2026

Holdings · Q3 2026

#SecuritySharesValueWeight
1PROTAGONIST THERAPEUTICS INCCOM2,449,183$345.1M45.30%
2NANOBIOTIXSPONSORED ADS5,623,816$175.2M23.01%
3MEIRAGTX HLDGS PLCCOM6,641,064$73.1M9.59%
4RAPPORT THERAPEUTICS INCCOM1,784,517$60.0M7.87%
5CONTINEUM THERAPEUTICS INCCL A1,979,173$26.6M3.49%
6CEREBRAS SYSTEMS INCCOM CL A128,649$22.9M3.00%
7XENCOR INCCOM748,062$18.7M2.45%
8LEGEND BIOTECH CORPSPONSORED ADS814,586$16.2M2.13%
9FATE THERAPEUTICS INCCOM3,379,064$8.0M1.05%
10CVRX INCCOM4,024,861$7.0M0.92%
5 more rows. Subscribe for $29/month to see every row, download the data and use the API.